Hepatitis C virus genotypes among intravenous drug users in Italy

Hepatology Research

Volumn 9, Issue 1, 1997, Pages 20-27

  Stroffolini, T ^a   Fiume, A ^b   Fatale, G ^b   Regni, F ^b   Ciccozzi, M ^a   Marzolini, A ^a   Mele, A ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Comunità Incontro ^*  (Italy)

Author keywords

Drug users; Genotypes; Hepatitis C; Italy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031465580     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(97)00084-3     Document Type: Article

References (27)

1. Esteban JI, Esteban R, Viladomi VL, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-7.
2. Van Den Hoek JAR, Van Haastrecht HJA, Goudsmit J. De Wolf F, Coutinho RA. Prevalence incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990;162:823-6.
3. Donahue JG, Nelson KE, Munoz A. Antibody to hepatitis C virus among cardiac surgery patients, homosexuals and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991;15:1206-11.
4. Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy: a multicentric seroepidemiological study. Ital J Gastroenterol 1991;23:555-8.
5. Love A, Stanzeit B. Hepatitis C virus infection in Iceland: a recently introduced blood-borne disease. Epidemiol Infect 1994;113:529-36.
6. Galeazzi B, Tufano A, Barbierato E, Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 1995;15:209-12.
7. Mele A, Stroffolini T, Pasquini P. Integrated epidemiological system for acute viral hepatitis report; 1984-1994. Istisan 1996;3:1-33.
8. Simmonds P. Variability of hepatitis C virus. Hepatology 1995;21:570-83.
9. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:132l-4.
10. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673-9.
11. Pontisso P, Ruvoletto MG, Nicoletti M. Distribution of three major hepatitis C virus genotypes in Italy. A multicenter study of 495 patients with chronic hepatitis C. J Vir Hep 1995;2:33-8.
12. Nosbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Mec 1995;1:111-20.
13. Dusheiko G, Schmilovitz-Weiss H, Brow D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-8.
14. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994;32:884-92.
15. Takada N, Takase S, Takada A, Takayasu D. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993;17:277-83.
16. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;172:934-98.
17. Cilla G, Garcia-Bengoechea M, Perez-Trallero E, Montalvo I, Vicente D, Arenas JI. Genotyping of hepatitis C virus isolates from Basque Country, Spain. Epidemiol Infect 1996;117:533-6.
18. Stark K, Schreier E, Muller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotypo among intravenous drug users in Berlin. Scand J Infect Dis 1995;27:331-7.
19. Silini E, Bono F, Cividini A, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995;22:651-95.
20. Love A, Sigurdsson JR, Stanzeit B, Briem H, Rikardsdottir H, Widell A. Characteristics of hepatitis C virus among intravenous drug users in Iceland. Am J Epidemiol 1996;143:631-6.
21. Rapicetta M, Attili AF, Mele A, et al. Prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in a urban population. J Med Virol 1992;37:87-92.
22. Okamoto H, Okada S, Sugiyama S, et al. The 5' terminal sequence of the hepatitis C virus genome. Jap J Exp Med 1990;60:167-77.
23. Mele A, Stroffolini T, Catapano R, Palumbo F, Moiraghi A, Novaco F. Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. Br Med J 1995;311:846-7.
24. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 1994;20:1131-6.
25. Alberti A, Morisca G, Chemello L. Hepatitis C. viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-8.
26. Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ. Liver histology in anti-HCV positive persons with normal or minimal elevated aminotranferases. J Clin Gastroenterol 1995;21:301-5.
27. Barrera JM, Bruguera M, Ercilla MG. Persistent hepatitis C viremia after acute self-limiting post-transfusion hepatitis C. Hepatology 1995;21:639-44.